Amwill Health Care Ltd IPO

Amwill Health Care Ltd IPO

Pharmaceuticals

sme

Bidding period

05 Feb 2025 - 07 Feb 2025

Bid price

₹111.00 - ₹111.00

Listing on

BSE-SME

Listing date

12 Feb 2025

Lot size

1200 shares

Issue size

₹59.98 crore


Minimum investment

₹1,33,200.00 / 1 lot

Maximum investment

₹1,33,200.00 / 1 lot

Bidding closed on 07 Feb 2025

EXPLORE IPOs
EXPLORE IPOs

Amwill Health Care Ltd IPO dates

IPO opening date

05 Feb 2025

IPO end date

07 Feb 2025

Allotment date

10 Feb 2025

Initiation of refunds

11 Feb 2025

Credit of shares to demat

11 Feb 2025

IPO listing date

12 Feb 2025

Amwill Health Care Ltd IPO financials

Particulars

For the period ending in March 2024 (in ₹ million)

Total assets ₹18.98
Total liabilities ₹18.98
Total expenditure ₹27.52
Total revenue ₹44.28
Profit after tax ₹12.54
EBITDA ₹17.00
Adjusted EBITDA ₹0.00

Amwill Health Care Ltd shareholder pattern

Pre-issue Post-issue
Promoter group 97.0 70.64
Public group 3.0 29.36

Amwill Health Care Ltd strengths and risks

Information currently unavailable

  • Extensive product portfolio supported by product formulation capabilities and dynamic advisory board of reputed dermatologists.

  • Long standing presence through our Promoters with strong brand equity.

  • Provision of high-quality product development through tie ups with contract manufacturers and prototype developers.

  • Well experienced management team with proven project management and implementation skills.

  • The company has appointed one of its Promoter Group entities, M/s. Amderma Healthcare LLP as a carrying and forwarding agent for storing, delivering and distributing its products. Consequently, the company derives all of its revenue from M/s. Amderma Healthcare LLP. Any non-performance or breach of covenants of the carrying and forwarding agreement executed with M/s. Amderma Healthcare LLP may adversely affect its business operations, profitability and cash flows.

  • The company relies on third party contract manufacturers for manufacturing products of the Company.

  • Its commercial success is largely dependent upon the company's ability to develop and devise problem solving dermacosmetic products. The company has developed a limited number of products since incorporation and therefore, its ability to innovate new products might be limited, which may have an adverse impact on its revenue and profitability.

  • The company derives a significant portion of its revenue from certain of the company products. If sales volume or price of such products declines in the future, or if the company is unable to sell such products for any reason, its business, financial condition, cash flows and results of operations could be adversely affected.

  • Its business and prospects may be adversely affected if the company is unable to maintain and grow the image of its brands. Further, pursuant to the Memorandum of Understanding dated March 31, 2020 executed between M/s. Amwill Healthcare and the Company ("Asset Transfer MoU"), its Promoter Anand Gandhi has transferred all the trademarks which were previously owned by M/s. Amwill Healthcare. The Company has made applications before the Registrar of Trademarks for registering the Asset Transfer MoU and change in ownership of the aforementioned trademarks, which are presently pending.

  • If the company is unable to anticipate and respond to changes in the market trends and changing customer preferences in a timely and effective manner, or if the company fails to maintain its reputation, brand value or increase the market for its products, the demand for the company products may decline.

  • Its business largely depends on the performance of the company marketing team. Further, the success of its products are dependent upon dermatologists and medical professionals accepting its products and prescribing them to their patients. Any non-performance by our marketing team to market its products before the dermatologists and medical professionals, may adversely affect its business operations, profitability and cash flows.

  • Its operations are concentrated in the states of Karnataka, Andhra Pradesh and Telangana. If revenues from these states decline, its business, results of operations and financial condition would be adversely affected.

  • If the company or M/s. Amderma Healthcare LLP are unable to collect its dues and receivables from end users, its results of operations and cash flows could be adversely affected.

  • Some of its Promoter Group entities may have conflicts of interest as they are engaged in similar industry segment and may compete with it.

How to check the allotment status of the Amwill Health Care Ltd IPO?

To check the IPO allotment status, follow these steps:

 

  1. Visit the official website of the IPO’s registrar.
  2. Go to the IPO allotment status page.
  3. Select the ‘Amwill Health Care Ltd’ from the list of available IPOs.
  4. Enter your PAN, Demat ID, or application number.
  5. Click on ‘Submit’ or ‘Check Status’ to view your allotment details.

Alternatively, you can also check the allotment status on stock exchange websites such as the NSE or BSE.

To check the IPO allotment status, follow these steps:

 

  1. Visit the official website of the IPO’s registrar.
  2. Go to the IPO allotment status page.
  3. Select the ‘Amwill Health Care Ltd’ from the list of available IPOs.
  4. Enter your PAN, Demat ID, or application number.
  5. Click on ‘Submit’ or ‘Check Status’ to view your allotment details.

Alternatively, you can also check the allotment status on stock exchange websites such as the NSE or BSE.

Read more Read less

Amwill Health Care Ltd IPO registrar

Bigshare Services Pvt Ltd

Phone number +91 226 263 8200;
E-mail ID investor@bigshareonline.com
Website www.bigshareonline.com

Amwill Health Care Ltd IPO reservation

QIB shares offered

10,26,000 (18.99%)

NII (HNI) shares offered

20,53,200 (38.0%)

Retail shares offered

20,53,200 (38.0%)

Anchor investor shares offered

0 (0.0%)

Total shares offered

54,03,600

Total shares with anchor investor

54,03,600

Amwill Health Care Ltd IPO lead manager

  • Unistone Capital Pvt Ltd

Explore other IPOs

Aditya Infotech Limited logo
Aditya Infotech Limited logo

Aditya Infotech Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Advance Agrolife Limited logo
Advance Agrolife Limited logo

Advance Agrolife Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Advanced SysTek Limited logo
Advanced SysTek Limited logo

Advanced SysTek Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Aegis Vopak Terminals Limited logo
Aegis Vopak Terminals Limited logo

Aegis Vopak Terminals Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Agilus Diagnostics Limited logo
Agilus Diagnostics Limited logo

Agilus Diagnostics Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Airox Technologies Limited logo
Airox Technologies Limited logo

Airox Technologies Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Ajay Poly Limited logo
Ajay Poly Limited logo

Ajay Poly Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
All Time Plastics Limited logo
All Time Plastics Limited logo

All Time Plastics Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Allchem Lifescience Limited logo
Allchem Lifescience Limited logo

Allchem Lifescience Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Amanta Healthcare Limited logo
Amanta Healthcare Limited logo

Amanta Healthcare Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Anand Rathi Share AND Stock Brokers Limited logo
Anand Rathi Share AND Stock Brokers Limited logo

Anand Rathi Share AND Stock Brokers Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Anlon Healthcare Limited logo
Anlon Healthcare Limited logo

Anlon Healthcare Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Anthem Biosciences Limited logo
Anthem Biosciences Limited logo

Anthem Biosciences Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
AOne Steels India Limited logo
AOne Steels India Limited logo

AOne Steels India Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Ardee Engineering Limited logo
Ardee Engineering Limited logo

Ardee Engineering Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Armee Infotech Limited logo
Armee Infotech Limited logo

Armee Infotech Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Asirvad Microfinance Limited logo
Asirvad Microfinance Limited logo

Asirvad Microfinance Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Ather Energy Limited logo
Ather Energy Limited logo

Ather Energy Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Atlanta Electricals Limited logo
Atlanta Electricals Limited logo

Atlanta Electricals Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Avanse Financial Services Limited logo
Avanse Financial Services Limited logo

Avanse Financial Services Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced

How to apply for an IPO with Bajaj Broking?

adafafds
 
 
  • Log in to the Bajaj Broking trading platform and select ‘IPO’ from the menu.
  • Browse the list of open IPOs and click ‘Apply’ for your chosen IPO.
  • Enter the quantity and your UPI ID.
  • Submit your application—and you're done!

Frequently asked questions

What is the listing date for the Amwill Health Care Ltd IPO?

The listing date for the Amwill Health Care Ltd IPO is 12 Feb 2025.

What is the issue size of Amwill Health Care Ltd IPO?

The issue size of the Amwill Health Care Ltd IPO is ₹59.98 cr.

What is the minimum lot size needed for Amwill Health Care Ltd IPO?

The minimum lot size for Amwill Health Care Ltd IPO is 1200

When does the Amwill Health Care Ltd open and close?

Amwill Health Care Ltd IPO is open from 05 Feb 2025 to 07 Feb 2025.

How can I apply for the Amwill Health Care Ltd IPO?

To apply for the Amwill Health Care Ltd, follow the steps given below:

  • Log in to your Bajaj Broking trading account and navigate to the current IPOs section.
  • Browse the list of open IPOs and click ‘Apply’ for your chosen PO.
  • Enter the quantity and your UPI ID. You will receive a mandate notification to block funds in your UPI app.
SHOW MORE SHOW LESS

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."

**Disclaimer: For Bajaj Financial Securities Limited

Investments in securities market are subject to market risk, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit. All leveraged intraday positions will be squared off the same day. There is no restriction on withdrawal of unutilised margin amount. Trade Recommendations are research-calls provided under the SEBI Research Analyst guidelines.
Visit https://www.bajajbroking.in/disclaimer for complete disclaimer.

Securities market Products/services are made available only at the discretion of BFSL and subject to the individual contractual terms and conditions of the respective Securities market products/services. You shall be the sole owner of any decision to invest in any BFSL's Securities market products/services.

Securities market products/services may be withdrawn or amended at any time by BFSL without notice and your recourse in such case would be directly to reach out BFSL at connect@bajajfinserv.in or 1800 833 8888.

Powered by Bajaj Financial Securities Limited (Bajaj Broking)